cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Bio Rad Laboratories Inc
17 own
13 watching
Current Price
$353.03
$-4.27
(-1.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
10,643.98M
52-Week High
52-Week High
509.62000
52-Week Low
52-Week Low
344.63000
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
6.5039
iconMarket Capitalization10,643.98M
icon52-Week High509.62000
icon52-Week Low344.63000
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio6.5039
What does the Bio Rad Laboratories Inc do?
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Read More
How much money does Bio Rad Laboratories Inc make?
News & Events about Bio Rad Laboratories Inc.
Stock Options Channel
3 months ago
Investors eyeing a purchase of Bio-Rad Laboratories Inc (BIO) stock, but tentative about paying the going market price of 375.00/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the August put ...
Stock Options Channel
4 months ago
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Dollar Tree Inc (DLTR), where a total volume of 56,921 contracts has been traded thus far today, a contract volume which is representative of approximately 5.7 million underlying ...
Ticker Report
6 months ago
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO Get Rating) have received an average recommendation of Buy from the six ratings firms that are currently covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy ...
Ticker Report
7 months ago
Bio-Rad Laboratories (NYSE:BIO Get Rating) had its price objective hoisted by Credit Suisse Group from $640.00 to $680.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on BIO. Royal Bank of Canada began coverage on Bio-Rad ...
Business Wire
7 months ago
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the companys management will participate in a fireside chat event during Citis 2023 Healthcare Services, MedTech, Tools & HCIT Conference on...
Frequently Asked Questions
Frequently Asked Questions
What is Bio Rad Laboratories Inc share price today?
plus_minus_icon
Can Indians buy Bio Rad Laboratories Inc shares?
plus_minus_icon
How can I buy Bio Rad Laboratories Inc shares from India?
plus_minus_icon
Can Fractional shares of Bio Rad Laboratories Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Bio Rad Laboratories Inc stocks?
plus_minus_icon
What is today’s traded volume of Bio Rad Laboratories Inc?
plus_minus_icon
What is today’s market capitalisation of Bio Rad Laboratories Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Bio Rad Laboratories Inc?
plus_minus_icon
What percentage is Bio Rad Laboratories Inc down from its 52-Week High?
plus_minus_icon
What percentage is Bio Rad Laboratories Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$353.03
$-4.27
(-1.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$0.39
$0.00 (0.97 %)
Novo Nordisk A/S
Novo Nordisk A/S
$91.30
$0.01 (0.01 %)
United Therapeutics Corporation
United Therapeutics Corporation
$222.74
$-0.94 (-0.42 %)
Emergent BioSolutions Inc
Emergent BioSolutions Inc
$3.26
$-0.18 (-5.23 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc.
$0.39
$0.00 (0.97 %)
Novo Nordisk A/S
Novo Nordisk A/S
$91.30
$0.01 (0.01 %)
United Therapeutics Corporation
United Therapeutics Corporation
$222.74
$-0.94 (-0.42 %)
Emergent BioSolutions Inc
Emergent BioSolutions Inc
$3.26
$-0.18 (-5.23 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00